EUVIMEDEUVIMED entdecken
Open Access

Clearing the Pulmonary Traffic Jam With Dual‐Enzyme Inhalable Nanoparticles Restore Airflow and Reverse Fibrotic Remodeling

Xue-Na Li, Xi-Xi Ma, Ya-Ping Lin, Hong-Tai Xu, Chun-Hui Cui, Jin-You Piao, Chao-Feng Zhang, Yan-Qiu Xu, Bing Wan iD, Lei Xing iD, Hu-Lin Jiang iD

Advanced Healthcare Materials · 2026-08 · 15 (29)

DOI: 10.1002/adhm.71381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 26.06.2026. Verfasst von Xue-Na Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Jiangning Hospital of Chinese Medicine, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Nanoparticles, Lung, Idiopathic Pulmonary Fibrosis. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Basic Research Program-Project, Jiangsu Province Chinese Medicine Science and Technology Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a progressive and life‐threatening interstitial lung disorder marked by aberrant mucus hypersecretion and excessive extracellular matrix (ECM) deposition, which together severely limit the effectiveness of current therapies. Although inhalation therapy enables localized pulmonary drug delivery, pathological mucus accumulation and ECM stiffening jointly form a “traffic jam‐like” physical obstruction that severely restricts drug penetration and retention. Here, we developed dual‐enzyme‐modified inhalable nanoparticles (Lipo/PFD‐CB) by co‐functionalizing the liposomal surface with bromelain and collagenase to synergistically overcome these obstructive barriers and enhance pulmonary delivery of the FDA‐approved antifibrotic drug pirfenidone (PFD). Specifically, bromelain cleaves mucin crosslinks to reduce mucus viscosity, while collagenase degrades dense ECM fibers to facilitate deep tissue penetration and prolonged retention. This dual‐enzyme remodeling strategy significantly improved aerosol deposition efficiency (86.5%) and optimized the pharmacokinetic profile and tissue distribution of PFD. In both early and advanced bleomycin‐induced fibrosis models, Lipo/PFD‐CB effectively attenuated profibrotic cellular activation and restored alveolar architecture and airflow. This study introduces an enzyme‐mediated, microenvironment‐remodeling inhalable nanoplatform that effectively “clears the pulmonary traffic jam,” restoring airflow and tissue homeostasis and offering a promising strategy to enhance therapeutic outcomes in IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesLungIdiopathic Pulmonary FibrosisAnimalsAdministration, InhalationPyridonesMiceMice, Inbred C57BLBleomycinLiposomes

Stichwörter der Autor:innen

dual‐enzyme modificationextracellular matrix penetrationmicroenvironment remodelingmucus viscositypulmonary traffic jam

Substanzen

PyridonespirfenidoneBleomycinLiposomes

Autor:innen und Institutionen

  • Affiliated Jiangning Hospital of Chinese Medicine, China Pharmaceutical University, Nanjing, China.
  • College of Pharmacy, Yanbian University, Yanji, China.
  • State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China.
  • Sino-Jan Joint Lab of Natural Health Products Research, School of Traditional Chinese Medicines, China Pharmaceutical University, Nanjing, China.
  • Nanjing Jiangning Hospital of Chinese Medicine, Nanjing, China.
  • Department of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Bing Wan, Lei Xing, Hu-Lin Jiang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Basic Research Program-Project
  • Jiangsu Province Chinese Medicine Science and Technology Development Project

Zitieren

APA

Li, X. N., Ma, X. X., Lin, Y. P., Xu, H. T., Cui, C. H., Piao, J. Y., Zhang, C. F., Xu, Y. Q., Wan, B., Xing, L., & Jiang, H. L. (2026). Clearing the Pulmonary Traffic Jam With Dual‐Enzyme Inhalable Nanoparticles Restore Airflow and Reverse Fibrotic Remodeling. Advanced Healthcare Materials, 15(29). https://doi.org/10.1002/adhm.71381

Vancouver

Li XN, Ma XX, Lin YP, Xu HT, Cui CH, Piao JY, et al. Clearing the Pulmonary Traffic Jam With Dual‐Enzyme Inhalable Nanoparticles Restore Airflow and Reverse Fibrotic Remodeling. Advanced Healthcare Materials. 2026;15(29). doi:10.1002/adhm.71381

BibTeX
@article{Li2026,
  author = {Li, Xue-Na and Ma, Xi-Xi and Lin, Ya-Ping and Xu, Hong-Tai and Cui, Chun-Hui and Piao, Jin-You and Zhang, Chao-Feng and Xu, Yan-Qiu and Wan, Bing and Xing, Lei and Jiang, Hu-Lin},
  title = {Clearing the Pulmonary Traffic Jam With Dual‐Enzyme Inhalable Nanoparticles Restore Airflow and Reverse Fibrotic Remodeling},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {29},
  doi = {10.1002/adhm.71381}
}
Kostenlos starten →